Study author | Year | Country | Ethnicity | Total cases/controls | Sex cases/controls | Genotyping method | Mean age Cases/Controls | Quality score |
---|---|---|---|---|---|---|---|---|
MMP9 | ||||||||
 Nelissen et al. | 2000 | Sweden | European | 199/146 | M = NR F=NR | PCR-RFLP | NR/NR | 6 |
 Zivkovic et al. | 2007 | Serbia | European | 187/282 | M = 67/140 F = 120/142 | Touch Down PCR | 35.5 ± 10.1/40.8 ± 14.8 | 7 |
 Benesova et al. | 2008 | Czech Republic | European | 244/132 | M = 63/45 F = 181/87 | PCR-SSP | 38.4 ± 10.2/35.6 ± 11.7 | 7 |
 Mirowska-Guzel et al. | 2009 | Poland | European | 234/190 | M = 66/76 F = 168/114 | PCR-RFLP | 40.09 ± 10.19/40.09 ± 10.19 | 7 |
 Fernandes et al. | 2009 | Brazil | South-American | 158/191 | M = 41/54 F = 117/137 | PCR-RFLP | 38.7 ± 13/35.6 ± 9.5 | 6 |
 La Russa et al. | 2010 | Italy | European | 243/173 | M = 96/107 F = 147/66 | PCR-RFLP | 41.1 ± 12.2/28.5 ± 9.4 | 7 |
 Valado et al. | 2017 | Portugal | European | 169/183 | M = 48/63 F = 121/120 | PCR-RFLP | 41.44 ± 0.84/39.09 ± 0.96 | 6 |
 Ibrahim et al. | 2019 | Egypt | African | 50/100 | M = 18/NR F = 32/NR | PCR-RFLP | 32.9 ± 8.1/NR | 5 |
 Sabbagh et al. | 2019 | Iran | Asian | 100/105 | M = 37/41 F = 63/64 | PCR-ARMS | 42.89 ± 10.48/46.52 ± 8.90 | 5 |
 Sadr et al. | 2019 | Iran | Asian | 170/200 | M = 121/142 F = 49/58 | PCR-RFLP | 33.34 ± 7.91/31.88 ± 9.79 | 7 |
MMP3 | ||||||||
 Djuric et al. | 2008 | Serbia | European | 184/236 | M = NR F=NR | Touch Down PCR | NR/NR | 7 |
 Rahimi et al. | 2016 | Iran | Asian | 121/106 | M = 24/17 F = 97/89 | PCR-RFLP | 35.3 ± 9.1/34.5 ± 11.4 | 6 |
MMP2 | ||||||||
 Benesova et al. | 2008 | Czech Republic | European | 240/132 | M = 60/45 F = 180/87 | PCR-SSP | 38.4 ± 10.2/35.6 ± 11.7 | 7 |
 Aksoy et al. | 2016 | Turkey | European | 102/102 | M = 76/75 F = 26/27 | Taq man | 36.69 ± 8.33/35.93 ± 8.20 | 6 |
 Liutkeviciene et al. | 2018 | Lithuania | European | 26/26 | M = NR F=NR | Taq man | 36/34 | 5 |